Skip to main content

Cost-effective reimbursement analysis for medical technologies in Europe

Procedure coding, payment mechanism, reimbursement tariffs, policy, and HTA considerations in 20 EU countries

Learn more
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Consultation on proposed increase of the Budget Impact Test threshold in England

On July 31, 2024, NHS England and the National Institute for Health and Care Excellence (NICE) published a consultation document that sets out the proposal to increase the Budget Impact Test (BIT) threshold from £20 million to £40 million. The BIT was introduced in 2017, and it applies during NICE's technology evaluation process.

NHS England and NICE are jointly responsible for the BIT threshold. NICE, through the Resource Impact Assessment (RIA) team, is responsible for independently assessing budget impact and identifying where the threshold is likely to be exceeded. At the same time, NHS England is responsible for commercial discussions following the identification of the threshold potentially being exceeded. 

Currently, the BIT threshold is considered exceeded if the budget impact is expected to be greater than £20 million in any of the first three years of a technology's use in the NHS. Budget impact and the application of the BIT do not influence NICE's consideration of the clinical and cost-effectiveness of a technology.

Increasing the BIT threshold to £40 million will ensure the BIT continues to target those technologies presenting the greatest budget impacts for the NHS while ensuring that the threshold is only exceeded in a minority of evaluations, in line with the intention of the original BIT policy.

The deadline for comments submission is September 25, 2024.

See the full details here.

This news is just one of about 300 market access news collected by our team in the premium subscription service Market Access Monitor every week from more than 80 organizations. Access our paid service to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Access is organized as an online Database and email alert formats. Contact us to get a free, three-month, no-obligation trial.

Tags